Article metrics

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

 

Online download statistics by month:

Online download statistics by month: October 2021 to February 2023

AbstractFullPdf
Oct 202116251604920
Nov 2021212921231564
Dec 2021140013971032
Jan 202220019867
Feb 202218818966
Mar 202231731091
Apr 202234534792
May 202230431094
Jun 2022360358103
Jul 2022245224641775
Aug 2022220222021645
Sep 202211731168918
Oct 202232231182
Nov 202240239377
Dec 202227927265
Jan 2023320315117
Feb 2023642639138
Total14660146008846